Tenax Therapeutics, Inc. TENX
1.81
(0.08)
(4.23%)
as of 25 Sep
- Market cap
- $70.0M
- P/E
- 0.0×
Follow TENX
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (59.80%) | (51.71%) | (55.64%) | (44.80%) |
+8 more TTM periods Free account |
|
| (57.02%) | (49.23%) | (52.36%) | (42.77%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(57.10%) | (50.49%) | (54.19%) | (45.03%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(0.90) | (0.84) | (0.91) | (0.65) | |
Free Cash Flow |
(46.03) | (38.14) | (35.80) | (25.91) | |
| Other line items | |||||
Cash ROIC |
(19.88%) | (16.34%) | (18.39%) | (13.25%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | — | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.71 | 0.66 | 0.68 | 0.60 | |
Depreciation/Fixed assets |
— | — | — | 0.00 | |
Capex/Depreciation |
— | — | — | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.90) | (0.84) | (0.91) | (0.65) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates